5 Most-Read Articles From Our 2020 Publication

Of course COVID-19 garnered most of the headlines in 2020. But the best-read stories from our print publication (which are subsequently posted on the website) covered a range of topics, from drugs in the pipeline to pulse oximeters to the top challenges for healthcare executives.

5. The Most Valuable Pipeline Drugs for 2020

Our predictions at the beginning of 2020 about the drugs headed for approval or sale. Reyvow (Lasmiditan), Adakveo (crizanlizumab-tmca) and Givlaari (givosiran) were on this pre-pandemic list.

Read the full article.

4. At-Home Pulse Oximeters: The ‘It’ Gadget of the COVID-19 Outbreak

At-home pulse oximeter purchases have spiked 500% in the months after COVID-19 pandemic hit the United States because the disease lowers oxygen levels. The American Lung Association sounded a cautious note, advising against buying the device unnecessarily.

Read the full article.

3. Five Healthcare Industry Changes to Watch in 2020

The 2020 trends we looked at included a shift from hospital to ambulatory settings, consolidation across the sector and effort to protect data privacy.

Read the full article.

2. Top Pharmacy Regulations for 2020: What Pharmacists Should Know

Our story looked at limits on opioids, provisions in the Drug Supply Chain Security Act and pharmacists prescribing hormonal contraceptives.

Read the full article.

1. Top 6 Challenges Healthcare Executives Will Face in 2020

COVID-19 overwhelmed every other challenges healthcare executives had in 2020. Our story in early January identified complying with new government regulations, a shift to value-based care and using big data as the hills that executives would be climbing in 2020.

Read the full article.